1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Diagnostic Self Evaluation: new trials by email Literature Review of Diagnostic Self Evaluation trials Research Report on Diagnostic Self Evaluation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions Dotarem (gadoterate meglumine), Magnevist (gadopentetate dimeglumine) - Diagnostic Self Evaluation, Central Nervous System Diseases | Phase 3 | Completed | Guerbet | 416 | 2010-09-01 | 2019-04-18 |
Central Nervous System Diseases (1)
Gadolinium DTPA (1) · gadoterate meglumine (1)
Guerbet (1)
Argentina (1) · Austria (1) · Brazil (1) · Chile (1) · France (1) · Germany (1) · Italy (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)